Unmasked adult-onset urea cycle disorders in the critical care setting

被引:91
作者
Summar, ML
Barr, F
Dawling, S
Smith, W
Lee, B
Singh, RH
Rhead, WJ
King, LS
Christman, BW
机构
[1] Vanderbilt Univ, Dept Pediat, Med Ctr, Ctr Human Genet Res,Div Med Genet, Nashville, TN 37232 USA
[2] Vanderbilt Childrens Hosp, Dept Pediat, Div Pediat Crit Care Med, Nashville, TN USA
[3] Vanderbilt Univ, Dept Pathol, Med Ctr, Nashville, TN 37232 USA
[4] Barbara Bush Childrens Hosp, Div Genet, Maine Med Ctr, Portland, ME USA
[5] Dept Pediat, Div Genet, Maine Pediat Specialty Grp, Portland, ME USA
[6] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[7] Emory Univ, Sch Med, Div Human Genet, Atlanta, GA USA
[8] Med Coll Wisconsin, Genet Ctr, Madison, WI USA
[9] Univ Washington, Seattle, WA 98195 USA
[10] Vanderbilt Univ, Dept Med, Med Ctr, Div Pulm & Crit Care Med, Nashville, TN 37232 USA
关键词
D O I
10.1016/j.ccc.2005.05.002
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Most often, urea cycle disorders have been described as acute onset hyperammonemia in the newborn period; however, there is a growing awareness that urea cycle disorders can present at almost any age, frequently in the critical care setting. This article presents three cases of adult-onset hyperammonemia caused by inherited defects in nitrogen processing in the urea cycle, and reviews the diagnosis, management, and pathophysiology of adult-onset urea cycle disorders. Individuals who have milder molecular urea cycle defects can lead a relatively normal life until a severe environmental stress triggers a hyperammonemic crisis. Comorbid conditions such as physical trauma often delay the diagnosis of the urea cycle defect. Prompt recognition and treatment are essential in determining the outcome of these patients.
引用
收藏
页码:S1 / +
页数:9
相关论文
共 45 条
[11]   PHENYLACETYLGLUTAMINE MAY REPLACE UREA AS A VEHICLE FOR WASTE NITROGEN-EXCRETION [J].
BRUSILOW, SW .
PEDIATRIC RESEARCH, 1991, 29 (02) :147-150
[12]   NEW PATHWAYS OF NITROGEN-EXCRETION IN INBORN-ERRORS OF UREA SYNTHESIS [J].
BRUSILOW, SW ;
VALLE, DL ;
BATSHAW, ML .
LANCET, 1979, 2 (8140) :452-454
[13]  
BRUSILOW SW, 1985, HOSP PRACT, V20, P65
[14]   Effects of hyperammonaemia on brain function [J].
Butterworth, RF .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 :6-20
[15]   HYPERAMINOACIDEMIA IN EPILEPTIC CHILDREN TREATED WITH VALPROIC ACID [J].
CASTROGAGO, M ;
RODRIGOSAEZ, E ;
NOVORODRIGUEZ, I ;
CAMINA, MF ;
RODRIGUEZSEGADE, S .
CHILDS NERVOUS SYSTEM, 1990, 6 (08) :434-436
[16]   MAGNETIC-RESONANCE SPECTROSCOPY SHOWS INCREASED BRAIN GLUTAMINE IN ORNITHINE CARBAMOYL TRANSFERASE DEFICIENCY [J].
CONNELLY, A ;
CROSS, JH ;
GADIAN, DG ;
HUNTER, JV ;
KIRKHAM, FJ ;
LEONARD, JV .
PEDIATRIC RESEARCH, 1993, 33 (01) :77-81
[17]   INHIBITION OF UREAGENESIS BY VALPROATE IN RAT HEPATOCYTES - ROLE OF N-ACETYLGLUTAMATE AND ACETYL-COA [J].
COUDE, FX ;
GRIMBER, G ;
PARVY, P ;
RABIER, D ;
PETIT, F .
BIOCHEMICAL JOURNAL, 1983, 216 (01) :233-236
[18]  
COULTER DL, 1980, LANCET, V1, P1310
[19]  
Davies SM, 1996, BONE MARROW TRANSPL, V17, P1119
[20]   VALPROATE-ASSOCIATED HEPATOTOXICITY AND ITS BIOCHEMICAL-MECHANISMS [J].
EADIE, MJ ;
HOOPER, WD ;
DICKINSON, RG .
MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1988, 3 (02) :85-106